What begins as one gift becomes expanding circles of impact.

Join us at the 2026 Red & White Ball to help fund BioBridge Global's mission to save and improve lives in San Antonio and beyond. 

About BioBridge Global

Since 1974, BioBridge Global has worked alongside the healthcare community to deliver lifesaving therapies and deliver innovations in the development of advanced therapies through its family of nonprofits, including:

Grow Our Blood Supply

Blood transfusions are the most common procedure in hospitals and South Texas Blood & Tissue (STB&T) plays a vital role in ensuring patients receive lifesaving care. Blood donors are more critical than ever.

of Texas depends on blood from STB&T

patients will need a blood transfusion

growing need in blood is being driven by rapid population growth in South Texas

Bringing Advanced Therapies Closer to Home

Cell and gene therapies begin with human cells donated by patients and healthy volunteers. These breakthroughs are transforming how cancer and auto-immune diseases are treated, but access remains limited:

  • Only 7 Texas Centers can deliver commercially available CAR T-CellTherapies

  • Due to access barriers, Only 20% of CAR T-Cell Therapy eligible patients receive treatment

  • Access to these therapies often depends on how far a patient can travel

In 2025, BBG Advanced Therapies launched the world’s first mobile leukapheresis center, bringing critical cell collection to underserved communities and closing gaps in cancer care.

Support Lifesaving Research

Philanthropic support can accelerate lifesaving work being done at BioBridge Global’s Center for Innovation and BioDesign, including:

  • Premiva™, a newly-patented testing platform that helps researchers develop new and effective therapies faster by:

    • Using microfluidics and miniaturization to accelerate the development of therapies against cancer and autoimmune diseases

    • Measuring and confirming how therapies work, including their mechanism of action

    • Providing clear, early insights that support regulatory approval

    • Detecting off-target binding early, helping reduce safety risks

  • Releasate™, a patent-pending growth medium supplement made from nontransfusable platelets that:

    • Enables human cells to be grown at scale, supporting cell therapies

    • Extends use of non-transfusable platelets, helping us be better stewards of this generous gift

“We’re forever grateful to the people who saved my life, and I hope my story will let people know how important donating blood is to saving lives.”

Because of Heroes in Arms donors, Mayah received an emergency blood transfusion on her way to the hospital after the Uvalde shooting.